Variations in zinc transporters are involved in multiple diseases, as indicated by the findings that a mutation in SLC30A8, which encodes ZnT8, affects type 2 diabetes risk, and that the knockout of ZIP13 influences beige adipocyte development. Here, SLC30A8 is linked to type 2 diabetes mellitus.